SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-19-015106
Filing Date
2019-12-16
Accepted
2019-12-16 16:33:15
Documents
53
Period of Report
2019-10-31

Document Format Files

Seq Description Document Type Size
1 10-Q csbr10-q10312019.htm 10-Q 785879
2 EXHIBIT 31.1 csbrq11031201910-qex311.htm EX-31.1 10396
3 EXHIBIT 31.2 csbrq11031201910-qex312.htm EX-31.2 10522
4 EXHIBIT 32.1 csbrq11031201910-qex321.htm EX-32.1 8261
  Complete submission text file 0001628280-19-015106.txt   4154060

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT csbr-20191031.xml EX-101.INS 856273
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT csbr-20191031.xsd EX-101.SCH 33493
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT csbr-20191031_cal.xml EX-101.CAL 57025
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT csbr-20191031_def.xml EX-101.DEF 119248
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT csbr-20191031_lab.xml EX-101.LAB 449183
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT csbr-20191031_pre.xml EX-101.PRE 244035
Mailing Address 855 N. WOLFE STREET SUITE 619 BALTIMORE MD 21205
Business Address 855 N. WOLFE STREET SUITE 619 BALTIMORE MD 21205 410-369-0365
CHAMPIONS ONCOLOGY, INC. (Filer) CIK: 0000771856 (see all company filings)

IRS No.: 521401755 | State of Incorp.: DE | Fiscal Year End: 0430
Type: 10-Q | Act: 34 | File No.: 001-11504 | Film No.: 191287526
SIC: 2836 Biological Products, (No Diagnostic Substances)